What does Blueprint Medicines Corp. do?

Jun 22 2025 06:48 PM IST
share
Share Via
Blueprint Medicines Corporation is a biopharmaceutical company focused on treating genomically defined diseases caused by abnormal kinase activation. As of March 2025, it reported net sales of $149 million and has a market capitalization of approximately $8.29 billion.
Overview:
Blueprint Medicines Corporation is a biopharmaceutical company that focuses on patients with genomically defined diseases driven by abnormal kinase activation, operating within the Pharmaceuticals & Biotechnology industry and classified as a mid-cap company.

Financial Snapshot:
Most recent Net Sales: 149 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: 0 Million (Quarterly Results - Mar 2025)
Market-cap: USD 8,292.13 Million (Mid Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: 0.21
Return on Equity: -45.52%
Price to Book: 24.24

Contact Details:
Address: 45 Sidney St, CAMBRIDGE MA : 02139-4133
Tel: ['1 617 3747580', '1 617 7146674']
Fax: 1 302 6555049
Website: http://www.blueprintmedicines.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Blueprint Medicines Corp. overvalued or undervalued?
Sep 20 2025 06:26 PM IST
share
Share Via
Is Blueprint Medicines Corp. overvalued or undervalued?
Jun 25 2025 09:04 AM IST
share
Share Via
How big is Blueprint Medicines Corp.?
Jun 22 2025 06:04 PM IST
share
Share Via